Carprofen (Rimadyl)
General educational overview for owners.
Meds A-Z
Carprofen
Detailed information about Carprofen
Official label facts
Owner quick guide first
Marketing clearly labeled
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Add to My Pet's Meds
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueReviewed / Updated / Sources
Reviewed: Not available
Updated: February 12, 2026, 7:40 PM UTC
Sources:
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Carprofen Tablets · official_label
- openFDA case USA-USFDACVM-2025-US-050545 · adverse_reaction
Pet Owner Quick Guide
Start here first for the simple next-step summary.
Used for:
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries
What to watch for:
- Avoid combining with other NSAIDs or corticosteroids
- Use caution with kidney/liver disease or GI ulcer history
- Tooth disorder (1 reports)
- Swollen limb (1 reports)
- Swollen feet (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Safety & side effects
What to watch:
- Avoid combining with other NSAIDs or corticosteroids
- Use caution with kidney/liver disease or GI ulcer history
- Tooth disorder
- Swollen limb
- Swollen feet
Most reported reactions:
- Tooth disorder (1 reports)
- Swollen limb (1 reports)
- Swollen feet (1 reports)
When to call your vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Videos
Video education and manufacturer materials for Carprofen.
Educational Videos
Manufacturer Videos
Rimadyl Chewable Tablets
Promotional
Disclosure:
Promotional distributor/manufacturer-linked content. This is not clinical guidance.
Product-focused video from a distributor source.
Data freshness: source data appears current.
Latest refresh: Mar 21, 2026, 10:02 a.m.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 7:40 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Mar 3, 2026, 11:04 AM UTC
Carprofen
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Dog
Manufacturer: Elanco
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Dog
Manufacturer: Elanco
Form: Caplet, Chewable Tablets, Flavored Tablets, Injectable Solution, Liquid (Solution), Scored Chewable Tablets
Identifiers:
ANADA: 200366
ANADA: 200397
ANADA: 200490
ANADA: 200498
ANADA: 200520
ANADA: 200522
ANADA: 200555
ANADA: 200575
ANADA: 200578
ANADA: 200593
ANADA: 200595
ANADA: 200681
ANADA: 200687
ANADA: 200703
ANADA: 200706
ANADA: 200732
ANADA: 200739
ANADA: 200762
ANADA: 200767
ANADA: 200777
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200575 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200366 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
- High: Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
Source metadata:
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
31
Serious reports
27
Species represented
2
Grouped by Body System
Digestive (3)
· Vomiting, Bloody diarrhoea, Loss of appetite
Skin & allergy (1)
· Itching
Other (28)
· Tooth disorder, Swollen limb, Swollen feet
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (20) Cat (12)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Digestive | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Skin & allergy | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Digestive | Dog | Unknown | - | - |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-050545
Storage & Handling
Store at room temperature in a dry place.
Documents
Owner handouts and official technical documents are grouped for faster access.
Owner handout (Client Information Sheet)
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/681
Owner handouts (1)
-
A-200687 client information sheet.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/681
Official label / PI (24)
-
UCM050400.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/41
-
UCM050400.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/42
-
A-200767-C-0019-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1738
-
A-200767-C-0019-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1739
-
VetprofenInserts.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/221
-
VetprofenCIS 1.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/222
-
Carofenvet_50mg_package_insert_v0125.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/2178
-
A-200687-R-0012-CS-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/682
-
A-200777-C-0015-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1958
-
A-200706-C-0023-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/998
-
A-200706-C-0023-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/999
-
A-200739-C-0001-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1458
-
A-200739-C-0001-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1459
-
A-200498-C-0099-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/746
-
A-200498-C-0099-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/747
-
A-200520-C-0044-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1344
-
N-141199-R-0060-CS-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1119
-
A-200703-A-0000-OT-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1018
-
A-200681-A-0000-OT-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/701
-
N-141053-C-0137-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/403
-
N-141053-C-0137-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/404
-
N-141111-C-0098-NL-AA_CIS.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/363
-
N-141111-C-0098-NL-AA_PI.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/364
-
ANADA 200522 package Insert_Redacted.pdf
· Labeling
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/223
SPL (25)
-
Carprofen Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2346/Carprofen%20Chewable%20Tablets
-
Novox® Caplets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/136/Novox%C2%AE%20Caplets
-
Carprofen Caplets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/135/Carprofen%20Caplets
-
Carprofen Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15186/Carprofen%20Tablets
-
Carprofen Flavored Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2266/Carprofen%20Flavored%20Tablets
-
Vetprofen™
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/215/Vetprofen%E2%84%A2
-
Carofenvet™
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15084/Carofenvet%E2%84%A2
-
Carprofen Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/9550/Carprofen%20Chewable%20Tablets
-
Carprofen
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15545/Carprofen
-
CARPROFEN Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/11053/CARPROFEN%20Chewable%20Tablets
-
CARPROFEN Soft Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/16125/CARPROFEN%20Soft%20Chewable%20Tablets
-
Carprofen
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/13590/Carprofen
-
CARPRIEVE®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2016/CARPRIEVE%C2%AE
-
Carprofen Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/13490/Carprofen%20Tablets
-
Carprieve® Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2385/Carprieve%C2%AE%20Injection
-
Rimadyl® Sterile Injectable Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/273/Rimadyl%C2%AE%20Sterile%20Injectable%20Solution
-
Carprofen Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/11093/Carprofen%20Tablets
-
Carprofen Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/9610/Carprofen%20Tablets
-
Carprofen
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/4680/Carprofen
-
Rimadyl® Caplets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1225/Rimadyl%C2%AE%20Caplets
-
Rimadyl® Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1399/Rimadyl%C2%AE%20Chewable%20Tablets
-
Carprofen Sterile Injectable Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2298/Carprofen%20Sterile%20Injectable%20Solution
-
Carprieve® Chewable Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2595/Carprieve%C2%AE%20Chewable%20Tablets
-
Carprofen Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2594/Carprofen%20Injection
-
quellin®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2206/quellin%C2%AE
FOI (30)
-
UCM433785.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1251
-
ucm059301.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1120
-
ucm059299.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1119
-
FOI Summary oA 200-767 Approved January 12, 2024.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14968
-
UCM443086.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1253
-
FOI Summary oA 200-762 Approved December 22, 2023.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14867
-
FOI Summary oA 200-687 Approved July 29, 2020.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/9508
-
FOI Summary oA 200-777 Approved April 10, 2024.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15304
-
FOI Summary oA 200-706 Approved June 28, 2021.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/11003
-
FOI Summary oA 200-795 Approved September 5, 2024.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15805
-
FOI Summary oA 200-739 Approved February 2, 2023.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13434
-
UCM167678.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1202
-
FOI Summary oA 200-732 Approved January 5, 2023.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13317
-
UCM408901.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1213
-
ucm117623.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/712
-
ucm117619.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/711
-
ucm117613.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/710
-
FOI Summary oA 200-703 Approved July 7, 2021.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/11043
-
FOI Summary oA 200-681 Approved August 4, 2020.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/9568
-
FOI Summary oA 200-490 Approved October 1, 2018.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/4860
-
UCM218511.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/586
-
ucm116543.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/585
-
UCM460231.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/584
-
UCM218513.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/642
-
ucm117153.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/641
-
ucm117151.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/640
-
UCM421902.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1214
-
FOI Summary oA 200-595 Approved April 28, 2017.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/223
-
FOI Summary oA 200-593 Approved April 19, 2017.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/222
-
UCM367497.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1237
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1251 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2346/Carprofen%20Chewable%20Tablets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1120 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1119 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/41 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/42 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/136/Novox%C2%AE%20Caplets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/135/Carprofen%20Caplets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14968 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1738 · document · Labeling
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 7:40 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Mar 3, 2026, 11:04 AM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
CARPRIEVE®
CARPROFEN Chewable Tablets
CARPROFEN Soft Chewable Tablets
Carofenvet™
Carprieve® Chewable Tablets
Carprieve® Injection
Carprofen
Carprofen Chewable Tablets
Carprofen Flavored Tablets
Carprofen Injection
Carprofen Sterile Injectable Solution
Carprofen Tablets
Novox® Caplets Carprofen Caplets
Rimadyl® Caplets
Rimadyl® Chewable Tablets
Rimadyl® Sterile Injectable Solution
Vetprofen™
quellin®
Case-reported brands (openFDA):
MSK
Catalog species: Dog
•
FDA-labeled species: Dog
Rx/OTC: RX
Form/route:
Caplet, Chewable Tablets, Flavored Tablets, Injectable Solution, Liquid (Solution), Scored Chewable Tablets, Soft Chewable Tablet, Tablet, Tablet (Chewable)
• Oral, Subcutaneous
Applications: ANADA 200-575 • ANADA 200-366 • ANADA 200-767 • ANADA 200-578 • ANADA 200-397 • ANADA 200-762 • ANADA 200-687 • ANADA 200-777 • ANADA 200-706 • ANADA 200-795 • ANADA 200-739 • ANADA 200-498 • ANADA 200-732 • ANADA 200-520 • NADA 141-199 • ANADA 200-703 • ANADA 200-681 • ANADA 200-490 • NADA 141-053 • NADA 141-111 • ANADA 200-522 • ANADA 200-595 • ANADA 200-593 • ANADA 200-555
NDC:
Packages
11695-6935-1
11695-6935-2
11695-7004-0
11695-7004-1
11695-7004-2
11695-7005-0
•
Products
11695
11695
11695
11695
11695
11695
Explore
Related conditions:
Osteoarthritis (Degenerative Joint Disease)
Osteoarthritis (Degenerative Joint Disease)
Pain (acute, chronic)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: M19.90
Unspecified osteoarthritis, unspecified site
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history. (Contraindication, High)
Top reaction signals
Tooth disorder (1)
Swollen limb (1)
Swollen feet (1)
Swollen face (1)
Skin lesion NOS (1)
Paralysis NOS (1)
Panting (1)
Neutropenia (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
ANADA: 200366
ANADA: 200397
ANADA: 200490
ANADA: 200498
ANADA: 200520
ANADA: 200522
ANADA: 200555
ANADA: 200575
ANADA: 200578
ANADA: 200593
ANADA: 200595
ANADA: 200681
ANADA: 200687
ANADA: 200703
ANADA: 200706
ANADA: 200732
ANADA: 200739
ANADA: 200762
ANADA: 200767
ANADA: 200777
ANADA: 200795
NADA: 141053
NADA: 141111
NADA: 141199
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 11695-6935-1 | 11695 | - | |
| 11695-6935-2 | 11695 | - | |
| 11695-7001-1 | 11695 | - | |
| 11695-7001-2 | 11695 | - | |
| 11695-7001-3 | 11695 | - | |
| 11695-7002-1 | 11695 | - | |
| 11695-7002-2 | 11695 | - | |
| 11695-7002-3 | 11695 | - | |
| 11695-7003-1 | 11695 | - | |
| 11695-7003-2 | 11695 | - | |
| 11695-7003-3 | 11695 | - | |
| 11695-7004-0 | 11695 | - | |
| 11695-7004-1 | 11695 | - | |
| 11695-7004-2 | 11695 | - | |
| 11695-7005-0 | 11695 | - | |
| 11695-7005-1 | 11695 | - | |
| 11695-7005-2 | 11695 | - | |
| 11695-7006-0 | 11695 | - | |
| 11695-7006-1 | 11695 | - | |
| 11695-7006-2 | 11695 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
UCM433785.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200575
-
UCM050400.pdf
• Official label • Official
• Aug. 26, 2025
FDA official labeling for application 200366
-
UCM050400.pdf
• Official label • Official
• Aug. 26, 2025
FDA official labeling for application 200366
-
ucm059299.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200366
-
ucm059301.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200366
-
A-200767-C-0019-NL-AA_PI.pdf
• Official label • Official
• March 20, 2025
FDA official labeling for application 200767
-
A-200767-C-0019-NL-AA_CIS.pdf
• Official label • Official
• March 20, 2025
FDA official labeling for application 200767
-
FOI Summary oA 200-767 Approved January 12, 2024.pdf
• FOI summary • Official
• March 20, 2025
FDA FOI summary for application 200767
-
UCM443086.pdf
• FOI summary • Official
• Feb. 24, 2025
FDA FOI summary for application 200578
-
VetprofenCIS 1.pdf
• Official label • Official
• Feb. 24, 2025
FDA official labeling for application 200397
-
VetprofenInserts.pdf
• Official label • Official
• Feb. 24, 2025
FDA official labeling for application 200397
-
Carofenvet_50mg_package_insert_v0125.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200762
-
FOI Summary oA 200-762 Approved December 22, 2023.pdf
• FOI summary • Official
• Feb. 5, 2025
FDA FOI summary for application 200762
-
A-200687-R-0012-CS-AA_PI.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200687
-
A-200687 client information sheet.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200687
-
FOI Summary oA 200-687 Approved July 29, 2020.pdf
• FOI summary • Official
• Feb. 5, 2025
FDA FOI summary for application 200687
-
A-200777-C-0015-NL-AA_PI.pdf
• Official label • Official
• Jan. 16, 2025
FDA official labeling for application 200777
-
FOI Summary oA 200-777 Approved April 10, 2024.pdf
• FOI summary • Official
• Jan. 16, 2025
FDA FOI summary for application 200777
-
A-200706-C-0023-NL-AA_PI.pdf
• Official label • Official
• Jan. 13, 2025
FDA official labeling for application 200706
-
A-200706-C-0023-NL-AA_CIS.pdf
• Official label • Official
• Jan. 13, 2025
FDA official labeling for application 200706
-
FOI Summary oA 200-706 Approved June 28, 2021.pdf
• FOI summary • Official
• Jan. 13, 2025
FDA FOI summary for application 200706
-
FOI Summary oA 200-795 Approved September 5, 2024.pdf
• FOI summary • Official
• Oct. 1, 2024
FDA FOI summary for application 200795
-
A-200739-C-0001-NL-AA_PI.pdf
• Official label • Official
• Aug. 17, 2023
FDA official labeling for application 200739
-
A-200739-C-0001-NL-AA_CIS.pdf
• Official label • Official
• Aug. 17, 2023
FDA official labeling for application 200739
-
FOI Summary oA 200-739 Approved February 2, 2023.pdf
• FOI summary • Official
• Aug. 17, 2023
FDA FOI summary for application 200739
-
A-200498-C-0099-NL-AA_PI.pdf
• Official label • Official
• April 20, 2023
FDA official labeling for application 200498
-
A-200498-C-0099-NL-AA_CIS.pdf
• Official label • Official
• April 20, 2023
FDA official labeling for application 200498
-
UCM167678.pdf
• FOI summary • Official
• April 20, 2023
FDA FOI summary for application 200498
-
FOI Summary oA 200-732 Approved January 5, 2023.pdf
• FOI summary • Official
• Feb. 1, 2023
FDA FOI summary for application 200732
-
A-200520-C-0044-NL-AA_PI.pdf
• Official label • Official
• Dec. 16, 2022
FDA official labeling for application 200520
-
UCM408901.pdf
• FOI summary • Official
• Dec. 16, 2022
FDA FOI summary for application 200520
-
N-141199-R-0060-CS-AA_PI.pdf
• Official label • Official
• March 21, 2022
FDA official labeling for application 141199
-
ucm117613.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
ucm117619.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
ucm117623.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
A-200703-A-0000-OT-AA_PI.pdf
• Official label • Official
• Aug. 2, 2021
FDA official labeling for application 200703
-
FOI Summary oA 200-703 Approved July 7, 2021.pdf
• FOI summary • Official
• Aug. 2, 2021
FDA FOI summary for application 200703
-
A-200681-A-0000-OT-AA_PI.pdf
• Official label • Official
• Sept. 1, 2020
FDA official labeling for application 200681
-
FOI Summary oA 200-681 Approved August 4, 2020.pdf
• FOI summary • Official
• Sept. 1, 2020
FDA FOI summary for application 200681
-
FOI Summary oA 200-490 Approved October 1, 2018.pdf
• FOI summary • Official
• Oct. 1, 2019
FDA FOI summary for application 200490
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 58
Clinical 2
Manufacturer 0
Marketing 0
Marketing/Manufacturer content exists: 1 linked manufacturer ad video are attached to this medication.
Current Field Facts
- overdose_info: Overdose can cause severe GI bleeding and kidney injury. Seek emergency veterinary care. (Clinical, 2026-02-12)
- storage_handling: Store at room temperature in a dry place. (Clinical, 2026-02-12)
- contraindications: Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history. (Official, 2026-02-12)
- side_effects: GI upset (vomiting/diarrhea), decreased appetite, lethargy. Rare: ulceration or liver enzyme elevations. (Official, 2026-02-12)
- usage: NSAID used for pain and inflammation (commonly osteoarthritis and post-operative pain in dogs). (Official, 2026-02-12)
Recent Revisions
- side_effects updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Carprofen Chewable Tablets
RX
Carprofen
Scored Chewable Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-575 | W | Aug 26, 2025 |
|
Novox® Caplets Carprofen Caplets
RX
Carprofen
Caplet
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-366 | W | Aug 26, 2025 |
|
Carprofen Tablets
RX
Carprofen
Flavored Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-767 | Approved | Mar 20, 2025 |
|
Carprofen Flavored Tablets
RX
Carprofen
Tablet
• Oral
|
Ajenat Pharmaceuticals LLC | ANADA 200-578 | Approved | Feb 24, 2025 |
|
Vetprofen™
RX
Carprofen
Caplet
• Oral
|
Ajenat Pharmaceuticals LLC | ANADA 200-397 | Approved | Feb 24, 2025 |
|
Carofenvet™
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-762 | Approved | Feb 5, 2025 |
|
Carprofen Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-687 | Approved | Feb 5, 2025 |
|
Carprofen
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-777 | Approved | Jan 16, 2025 |
|
CARPROFEN Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-706 | Approved | Jan 13, 2025 |
|
CARPROFEN Soft Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-795 | Approved | Oct 1, 2024 |
|
Carprofen
RX
Carprofen
Chewable Tablets
• Oral
|
ZYVET AH, Inc. | ANADA 200-739 | Approved | Aug 17, 2023 |
|
CARPRIEVE®
RX
Carprofen
Tablet
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-498 | Approved | Apr 20, 2023 |
|
Carprofen Tablets
RX
Carprofen
Caplet
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-732 | Approved | Feb 1, 2023 |
|
Carprieve® Injection
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Norbrook Laboratories, Ltd. | ANADA 200-520 | Approved | Dec 16, 2022 |
|
Rimadyl® Sterile Injectable Solution
RX
Carprofen
Liquid (Solution)
• Subcutaneous
|
Zoetis Inc. | NADA 141-199 | Approved | Mar 21, 2022 |
|
Carprofen Tablets
RX
Carprofen
Caplet
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-703 | Approved | Aug 2, 2021 |
|
Carprofen Tablets
RX
Carprofen
Flavored Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-681 | Approved | Sep 1, 2020 |
|
Carprofen
RX
Carprofen
Chewable Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-490 | Approved | Oct 1, 2019 |
|
Rimadyl® Caplets
RX
Carprofen
Caplet
• Oral
|
Zoetis Inc. | NADA 141-053 | Approved | Aug 27, 2019 |
|
Rimadyl® Chewable Tablets
RX
Carprofen
Tablet (Chewable)
• Oral
|
Zoetis Inc. | NADA 141-111 | Approved | Jul 1, 2019 |
|
Carprofen Sterile Injectable Solution
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Dechra Veterinary Products LLC | ANADA 200-522 | Approved | Jun 12, 2018 |
|
Carprieve® Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-595 | Approved | May 1, 2017 |
|
Carprofen Injection
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Accord Healthcare, Inc. | ANADA 200-593 | Approved | May 1, 2017 |
|
quellin®
RX
Carprofen
Soft Chewable Tablet
• Oral
|
Elanco US Inc. | ANADA 200-555 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg, and 100 mg tablets
Label highlights
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments
Limitations
Federal Law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each caplet contains 25, 75, or 100 milligrams (mg) carprofen.
Dogs
Indication
For the relief of pain and inflammation
associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
Dosage
2 milligram per pound of body weight once daily or 1 milligram per pound twice daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg, or 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
2 milligram per pound (4.4 mg/kg) of body weight once daily or 1 milligram per pound twice daily.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Label highlights
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2. mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each caplet or chewable tablet contains 25, 75, or 100 milligrams (mg) carprofen.
Dogs
Indication
For the control of postoperative pain associated with soft tissue and orthopedic surgery. For the relief of pain and inflammation associated with osteoarthritis
Dosage
2 milligram per pound of body weight once daily or 1 milligram per pound twice daily.
Limitations
For the control of postoperative pain, administer approximately 2 hours before the procedure. Federal law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
50 mg/mL
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 37.5 mg, 50 mg, 75 mg, and 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. For scored tablets, dosage should be calculated in half-tablet increments.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
50 mg/mL
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg, and 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. For scored tablets, dosage should be calculated in half-tablet increments.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
25 mg, 75 mg, or 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg and 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Carprofen chewable tablets are scored and dosage should be calculated in half-tablet increments.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each caplet or chewable tablet contains 25, 75, or 100 milligrams (mg) carprofen.
Dogs
Indication
Carprofen is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries In dogs.
Dosage
2 milligram per pound of body weight once daily or 1 milligram per pound twice daily.
Limitations
For use in dogs only. Do not use in cats.
Carprofen should not be used in dogs exhibiting previous hypersensitivity to carprofen.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg, or 100 mg of carprofen per caplet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter (mL) contains 50 milligrams (mg) of carprofen.
Label highlights
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 50 milligrams carprofen.
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
Dosage
2 milligram per pound (4.4 milligrams per kilogram) body weight once daily or 1 milligram per pound (2.2 milligrams per kilogram) body weight twice daily, by subcutaneous injection.
Limitations
For use in dogs only. Do not use in cats.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25, 75, or 100 mg carprofen per caplet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25 mg, 75 mg, or 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
25 mg, 75 mg, and 100 mg of carprofen per tablet
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue
and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each caplet or chewable tablet contains 25, 75, or 100 milligrams (mg) carprofen.
Dogs
Indication
For the control of postoperative pain associated with soft tissue and orthopedic surgery. For the relief of pain and inflammation associated with osteoarthritis.
Dosage
2 milligram per pound (4.4 mg/kg) of body weight once daily or 1 milligram per pound twice daily.
Limitations
For use in dogs only. Not for use in cats. For the control of postoperative pain, administer approximately 2 hours before the procedure. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each caplet or chewable tablet contains 25, 75, or 100 milligrams (mg) carprofen.
Dogs
Indication
Rimadyl is indicated for the relief of pain and inflammation associated with osteoarthritis and
for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
2 milligram per pound of body weight once daily or 1 milligram per pound twice daily.
Limitations
For use in dogs only. Do not use in cats.
For the control of postoperative pain, administer approximately 2 hours before the procedure
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
50 mg/mL
Label highlights
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before the procedure.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25, 75, and 100 mg tablet strengths
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Dosage
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
Limitations
Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
50 mg/mL
Dogs
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
Dosage
2 mg/lb. (4.4 mg/kg) body weight once daily or 1 mg/lb. pound (2.2 mg/kg) body weight twice daily.
Limitations
For use in dogs only. Do not use in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
25, 75, and 100 mg
Label highlights
Indication
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs
Dosage
2 mg per pound (lb) of body weight once daily or 1 mg/lb twice daily for the control of postoperative pain; administer approximately 2 hours before procedure
Limitations
Federal Law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
Documents
-
FOI UCM433785.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm059301.pdf
Summary
This application provides for the additional indication for the control of postoperative pain associated with soft tissue and orthopedic surgeries. -
FOI ucm059299.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis in dogs. -
Labeling UCM050400.pdf
-
Labeling UCM050400.pdf
SPL Packages
- Novox® Caplets (ZIP)
- Carprofen Caplets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200767-C-0019-NL-AA_CIS.pdf
-
Labeling A-200767-C-0019-NL-AA_PI.pdf
SPL Packages
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM443086.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Labeling VetprofenInserts.pdf
-
Labeling VetprofenCIS 1.pdf
SPL Packages
- Vetprofen™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
- Carofenvet™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200687-R-0012-CS-AA_PI.pdf
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200777-C-0015-NL-AA_PI.pdf
SPL Packages
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200706-C-0023-NL-AA_CIS.pdf
-
Labeling A-200706-C-0023-NL-AA_PI.pdf
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200739-C-0001-NL-AA_CIS.pdf
-
Labeling A-200739-C-0001-NL-AA_PI.pdf
SPL Packages
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM167678.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
Labeling A-200498-C-0099-NL-AA_CIS.pdf
-
Labeling A-200498-C-0099-NL-AA_PI.pdf
SPL Packages
- CARPRIEVE® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM408901.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
Labeling A-200520-C-0044-NL-AA_PI.pdf
SPL Packages
- Carprieve® Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm117623.pdf
Summary
This supplement to NADA 141-199 provides revisions to 21CFR 522.312 (2) Indications for Use. To add a claim for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
FOI ucm117619.pdf
Summary
provides for the addition of a once daily administration of 2 mg/lb (4.4 mg/kg) of body weight in addition to a twice daily administration of 1 mg/lb (2.2 mg/kg) by subcutaneous injection. -
FOI ucm117613.pdf
Summary
Rimadyl® Injectable is indicated for the relief of pain and inflammation associated with -
Labeling N-141199-R-0060-CS-AA_PI.pdf
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200703-A-0000-OT-AA_PI.pdf
SPL Packages
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200681-A-0000-OT-AA_PI.pdf
SPL Packages
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM218511.pdf
Summary
To add a claim for the control of postoperative pain associated with soft tissue and orthopedic surgery in dogs. -
FOI ucm116543.pdf
Summary
This supplement provides for flexibility in administration of the total daily dose of Rimadyl® caplets. The drug may be administered orally at 2 milligrams per pound of body weight once daily or 1 milligram per pound of body weight twice daily. -
FOI UCM460231.pdf
Summary
RIMADYL® is indicated for the relief of pain and inflammation in dogs. RIMADYL was shown to be clinically effective for the reflief of signs associated with osteoarthritis in dogs. -
Labeling N-141053-C-0137-NL-AA_CIS.pdf
-
Labeling N-141053-C-0137-NL-AA_PI.pdf
SPL Packages
- Rimadyl® Caplets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM218513.pdf
Summary
For an additional claim for carprofen chewable tablets for the control of postoperative pain associated with soft tissue and orthopedic surgery in dogs. -
FOI ucm117153.pdf
Summary
This supplement provides for flexibility in administration of the total daily dose of Rimadyl® Chewable Tablets. The drug may be administered orally at 2 milligrams per pound of body weight once daily or 1 milligram per pound of body weight twice daily -
FOI ucm117151.pdf
Summary
Rimadyl® chewable tablets are indicated for the relief of pain and inflammation associated with osteoarthritis in dogs. -
Labeling N-141111-C-0098-NL-AA_CIS.pdf
-
Labeling N-141111-C-0098-NL-AA_PI.pdf
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM421902.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
SPL Packages
- Carprofen Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM367497.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
SPL Packages
- quellin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
NSAID used for pain and inflammation (commonly osteoarthritis and post-operative pain in dogs).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
Side Effects
GI upset (vomiting/diarrhea), decreased appetite, lethargy. Rare: ulceration or liver enzyme elevations.
Source: FDA openFDA • Reference
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Vomiting (1)
• Dog
Bloody diarrhoea (1)
• Cat
Loss of appetite
• Dog
Showing top 5 for Digestive.
Skin & allergy
Itching (1)
• Dog
Showing top 5 for Skin & allergy.
Other
Tooth disorder (1)
• Dog
Swollen limb (1)
• Dog
Swollen feet (1)
• Dog
Swollen face (1)
• Dog
Skin lesion NOS (1)
• Cat
Show more (23)
Paralysis NOS (1)
• Dog
Panting (1)
• Dog
Neutropenia (1)
• Dog
Lymphocytosis (1)
• Dog
Low thyroxine (1)
• Dog
Localised pain NOS (1)
• Dog
Intentional misuse (1)
• Cat
Hyperphosphataemia (1)
• Cat
Hyperglycaemia (1)
• Cat
Hind limb paresis (1)
• Dog
Hiding (1)
• Cat
Haematemesis (1)
• Cat
General illness (1)
• Cat
Fever (1)
• Dog
Eosinophilia (1)
• Dog
Enamel disorder (1)
• Dog
Elevated gamma-glutamyl transferase (1)
• Dog
Elevated aspartate aminotransferase (1)
• Dog
Elevated alanine aminotransferase (1)
• Cat
Dilated pupils (1)
• Cat
Death by euthanasia (1)
• Cat
Anaphylaxis (1)
• Dog
Accidental exposure (1)
• Cat
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Retriever - Golden, Male, 5 year, 36 kilogram • Drug: MSK, Tablet, chewable, Oral, Frequency: 1 per day • Reactions: Vomiting • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-056005
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 5.00 Year
- Weight: 36.000 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet, chewable
- Frequency: 1 per day
Reactions Reported:
Vomiting
Outcomes: Recovered/Normal
Dog, Dog (unknown), Male, 14 year, 33.566 kilogram • Drug: MSK, Solution/drops, Unknown • Reactions: Hind limb paresis • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055509
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 14.00 Year
- Weight: 33.566 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Solution/drops
Reactions Reported:
Hind limb paresis
Outcomes: Ongoing
Dog, Pit Bull, Female, 8.5 year, 23.587 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per dose, Frequency: 1 per day • Reactions: Elevated alanine aminotransferase, Elevated aspartate aminotransferase, Elevated gamma-glutamyl transferase, Low thyroxine • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055526
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 8.50 Year
- Weight: 23.587 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per dose
- Frequency: 1 per day
Reactions Reported:
Elevated alanine aminotransferase
Elevated aspartate aminotransferase
Elevated gamma-glutamyl transferase
Low thyroxine
Outcomes: Outcome Unknown
Dog, ['Dachshund - Standard Long-haired', 'Dog (unknown)'], Male, 12 year, 8.936 kilogram • Drug: MSK, Unknown • Reactions: Fever, Panting, Swollen limb, Localised pain NOS, Paralysis NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055637
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 12.00 Year
- Weight: 8.936 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Fever
Panting
Swollen limb
Localised pain NOS
Paralysis NOS
Outcomes: Ongoing
Dog, ['Chihuahua', 'Dog (unknown)'], Male, 10.75 year, 5.715 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Anaphylaxis, Swollen face, Itching, Swollen feet • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-055955
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 10.75 Year
- Weight: 5.715 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Anaphylaxis
Swollen face
Itching
Swollen feet
Outcomes: Recovered/Normal
Dog, ['Shepherd Dog - German', 'Dog (unknown)'], Female, 2.5 year • Drug: MSK, Subcutaneous, Dose: 0.95 mL per animal • Reactions: Neutropenia, Eosinophilia, Lymphocytosis, Enamel disorder, Tooth disorder • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055809
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 2.50 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 0.95 mL per animal
Reactions Reported:
Neutropenia
Eosinophilia
Lymphocytosis
Enamel disorder
Tooth disorder
Outcomes: Outcome Unknown
Cat, Cat (unknown), Female, 4.05 kilogram • Drug: MSK, Tablet, Oral, Dose: 50 Milligram per animal, Frequency: 24 per hour • Reactions: Hyperglycaemia • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054116
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Weight: 4.050 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 50 Milligram per animal
- Frequency: 24 per hour
Reactions Reported:
Hyperglycaemia
Outcomes: Outcome Unknown
Cat, Cat (other), Female • Drug: MSK, Injection, Unknown • Reactions: General illness, Death by euthanasia, Intentional misuse • Outcome: Euthanized
- Report ID: USA-USFDACVM-2025-US-050538
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Injection
Reactions Reported:
General illness
Death by euthanasia
Intentional misuse
Outcomes: Euthanized
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
Overdose can cause severe GI bleeding and kidney injury. Seek emergency veterinary care.
Storage & Handling
Store at room temperature in a dry place.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.